MedPath

High-intensity Interval Training and Vitamin D Effects on Bone Metabolism Among Women Diagnosed With Osteoporosis

Completed
Conditions
Osteoporosis
Exercise Overtraining
Vitamin D 25-Hydroxylase Deficiency
Interventions
Other: vitamin D supplements fo 16 weks
Registration Number
NCT06624657
Lead Sponsor
King Saud University
Brief Summary

The effects of 16-week high-intensity interval training (HIIT) and vitamin D supplements on bone mineral density (BMD) in women with osteoporosis. The participants assigned for HITT exercise training with or without vitamin D supplements for 16 weeks, and the levels of serum bone parameters like, Osteocalcin (OC), Ca, and s-BAP were estimated in women with osteoporosis at baseline and after post-training interventions. In addition, the levels of Vitamin D were also identified in all women's accordingly.

Detailed Description

our study aimed to investigate the effects of 16-week high-intensity interval training (HIIT) and vitamin D supplements on bone mineral density (BMD) in women with osteoporosis. thus, Serum levels of 25-Hydroxy-vitamin D (OH-D), Osteocalcin (OC), Ca, and s-BAP were estimated in women with osteoporosis at baseline and after post-training interventions. One-hundred twenty sedentary women aged (30-50 years) were diagnosed with osteoporosis. Patients were classified into four groups, 30 patients in each group; Control group (normal daily activities); Exercise group (HIIT-exercise for 16 weeks); Vitamin D group (vitamin D 800IU/ day for 16 weeks), and Concurrent group (HIIT exercise plus vitamin D for 16 weeks). Anthropometric measurements, BMD, serum levels of vitamin 25-(OH) D, Osteocalcin, s-BAP, and calcium were estimated in all participants' pre- and post-exercise training.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • A healthy non-smoker premenopausal women's
  • Age are 30-50 years old
  • subjects who diagnosed with osteoporosis based on the clinical features of bone mineral density (BMD) measured from both lumbar spine L2 to L4, and from the right and left sides of the hip region by Dual Energy X-ray Absorptiometry (DEXA, UNIGAMMA PLUS AC 230V 50/60Hz 400w, USA) scan method.
Exclusion Criteria
  • Women with; physical disability,
  • abnormal hormonal levels
  • severe disease complications such as chronic kidney and liver diseases,
  • rheumatoid and osteoarthritis diseases
  • significant overweight (BMI ≥25) and obesity (≥30 kg/m2) per recommended by the World Health Organization
  • history of receiving calcium, multivitamin supplements, corticosteroids, anticonvulsants, and heparin which might affects up on the assessment of bone markers and BMD measurements were excluded from this study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control groupvitamin D supplements fo 16 weksParticipants are women with osteoporosis Characterized by normal daily activities and diets
Exercise groupvitamin D supplements fo 16 weksParticipants are women's with osteoporosis participated in HIIT-exercise program interventions for 16 weeks
Vitamin D groupvitamin D supplements fo 16 weksParticipants are women's with osteoporosis who received vitamin D 800IU/ day for 16 weeks
Concurrent groupvitamin D supplements fo 16 weksParticipants are women's with osteoporosis who shared for HIIT exercise program plus vitamin D for 16 weeks
Primary Outcome Measures
NameTimeMethod
Anthropometric measurements4 month

BMI measurements were evaluated

Secondary Outcome Measures
NameTimeMethod
Assessments of bone mineral density (BMD)4 month

Before and after training along with vitamin D supplements, BMD of the lumbar spine

Assessments of bone serum markers and vitamin 25(OH) D4 month

Considering the fifth day of the female monthly period (8-10 hours fasting), blood samples were taken from all participants following overnight fasting and within 48 hours before starting the test and just following 16-week exercise training and receiving vitamin D supplements.

© Copyright 2025. All Rights Reserved by MedPath